Assembly Biosciences, Inc.
HEPATITIS B CORE PROTEIN MODULATORS
Last updated:
Abstract:
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound of formula: ##STR00001##
Status:
Application
Type:
Utility
Filling date:
14 Jan 2021
Issue date:
27 Jan 2022